NCT07059624 Femoral Arterial Cannulation in Pediatrics
| NCT ID | NCT07059624 |
| Status | Recruiting |
| Phase | — |
| Sponsor | American University of Beirut Medical Center |
| Condition | Pediatric ALL |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-07-09 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-07-09 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial\] is to evaluate the efficacy and safety of the ultrasound-guided "Modified Dynamic Needle Tip Positioning Short-Axis, Out-Of-Plane" (MDNTP-SAOP) technique compared to the "Conventional, Short-Axis, Out-Of-Plane" (C-SAOP) technique for femoral arterial cannulation performed by anesthesia residents in children. The main question it aims to answer is: What is the time required for attempted femoral arterial cannulation by anesthesia residents at the first puncture site? Researchers will compare the efficacy and safety of MDNTP-SAOP versus C-SAOP methods for femoral arterial cannulation performed by anesthesia residents in infants and children undergoing cardiac surgery. Participants will be randomized to either the MDNTP-SAOP or the C-SAOP group. Intraoperatively, time taken for attempted cannulation by the resident at the first site of femoral arterial puncture, number of attempts at arterial cannulation, and number of cannulae required for successful cannula insertion will be recorded. Adverse events will be monitored on postoperative days 1 and 3. The insertion site will be examined for thrombosis, hematoma, infection, or limb ischemia distal to the insertion site
Eligibility Criteria
Inclusion Criteria: * Infants and children under 12 years of age. * American Society of Anesthesiologist (ASA) physical status II-IV. * Patients with congenital heart disease undergoing cardiac surgery who do not have existing arterial line access. Exclusion Criteria: * Need for emergency surgery. * Hemodynamic instability.
Contact & Investigator
Amro Khalili, MD
PRINCIPAL INVESTIGATOR
American University of Beirut Medical Center
Frequently Asked Questions
Who can join the NCT07059624 clinical trial?
This trial is open to participants of all sexes, up to 12 Years, studying Pediatric ALL. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07059624 currently recruiting?
Yes, NCT07059624 is actively recruiting participants. Contact the research team at ak151@aub.edu.lb for enrollment information.
Where is the NCT07059624 trial being conducted?
This trial is being conducted at Beirut, Lebanon.
Who is sponsoring the NCT07059624 clinical trial?
NCT07059624 is sponsored by American University of Beirut Medical Center. The principal investigator is Amro Khalili, MD at American University of Beirut Medical Center. The trial plans to enroll 80 participants.